These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 29896197)

  • 21. Advances and challenges towards a vaccine against Chagas disease.
    Quijano-Hernandez I; Dumonteil E
    Hum Vaccin; 2011 Nov; 7(11):1184-91. PubMed ID: 22048121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ
    Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination With Recombinant Filamentous
    Gomes-Neto JF; Sartorius R; Canto FB; Almeida TS; Dias AA; Barbosa CD; Melo GA; Oliveira AC; Aguiar PN; Machado CR; de Matos Guedes HL; Santiago MF; Nóbrega A; De Berardinis P; Bellio M
    Front Immunol; 2018; 9():1173. PubMed ID: 29896197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.
    Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M
    PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
    Front Immunol; 2019; 10():1456. PubMed ID: 31293599
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
    Chowdhury IH; Lokugamage N; Garg NJ
    Front Immunol; 2020; 11():595039. PubMed ID: 33414785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Trypanosoma cruzi Trans-sialidase on the Escape from Host Immune Surveillance.
    Nardy AF; Freire-de-Lima CG; Pérez AR; Morrot A
    Front Microbiol; 2016; 7():348. PubMed ID: 27047464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current drug therapy and pharmaceutical challenges for Chagas disease.
    Bermudez J; Davies C; Simonazzi A; Real JP; Palma S
    Acta Trop; 2016 Apr; 156():1-16. PubMed ID: 26747009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205.
    D'Apice L; Costa V; Sartorius R; Trovato M; Aprile M; De Berardinis P
    J Immunol Res; 2015; 2015():585078. PubMed ID: 26380324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells.
    Helft J; Böttcher J; Chakravarty P; Zelenay S; Huotari J; Schraml BU; Goubau D; Reis e Sousa C
    Immunity; 2015 Jun; 42(6):1197-211. PubMed ID: 26084029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
    Deng L; Ibañez LI; Van den Bossche V; Roose K; Youssef SA; de Bruin A; Fiers W; Saelens X
    PLoS One; 2015; 10(5):e0126650. PubMed ID: 25973787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response.
    Sartorius R; D'Apice L; Trovato M; Cuccaro F; Costa V; De Leo MG; Marzullo VM; Biondo C; D'Auria S; De Matteis MA; Ciccodicola A; De Berardinis P
    EMBO Mol Med; 2015 Jul; 7(7):973-88. PubMed ID: 25888235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
    Dc-Rubin SS; Schenkman S
    Cell Microbiol; 2012 Oct; 14(10):1522-30. PubMed ID: 22747789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.
    Vasconcelos JR; Bruña-Romero O; Araújo AF; Dominguez MR; Ersching J; de Alencar BC; Machado AV; Gazzinelli RT; Bortoluci KR; Amarante-Mendes GP; Lopes MF; Rodrigues MM
    PLoS Pathog; 2012; 8(5):e1002699. PubMed ID: 22615561
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.